buy

Johnson & Johnson buy Raymond James

Johnson & Johnson

Start price

€149.60

/ 50%

Target price

05.09.24

Performance (%)

End price

€148.66

Summary

This prediction ended on with a price of €148.66. During the runtime of the prediction for Johnson & Johnson the price only changed by . Raymond_James has a follow-up prediction for Johnson & Johnson where he still thinks Johnson & Johnson is a Buy. Dividends of are taken into consideration when calculating the performance. Raymond_James has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Feedback

Performance without dividends (%)

Name	1w	1m	1y
Johnson & Johnson
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Raymond_James for this prediction

In the thread Johnson & Johnson diskutieren

Prediction Buy

Perf. (%)

Target price 166.506

Change

Ends at

Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Raymond James from $184.00 to $179.00. They now have an "outperform" rating on the stock.

Ratings data for JNJ provided by MarketBeat

Raymond James